PNPLA3, TM6SF2, and MBOAT7 Influence on Nutraceutical Therapy Response for Non-alcoholic Fatty Liver Disease: A Randomized Controlled Trial. The gene discussed is PNPLA3; the disease is metabolic dysfunction-associated steatotic liver disease.